Howard, Ellen M. https://orcid.org/0000-0002-8166-8779
Massetti, Marc
Chua, Gin Nie
Gaydon, Millie
Savar, Sara
Lloyd, Andrew
Funding for this research was provided by:
Servier Pharmaceuticals LLC
Article History
Received: 10 April 2025
Accepted: 21 August 2025
First Online: 6 September 2025
Declarations
:
: The study was funded by Servier Pharmaceuticals LLC.
: Ellen M. Howard, Gin Nie Chua, Millie Gaydon and Sara Savar are employees of Acaster Lloyd Consulting Ltd. Andrew Lloyd is an employee and shareholder of Acaster Lloyd Consulting Ltd. Acaster Lloyd Consulting Ltd were commissioned by Servier Pharmaceuticals LLC, the study sponsor, to conduct the study. Marc Massetti is an employee of Servier Pharmaceuticals LLC.
: Ellen M. Howard: investigation, methodology, formal analysis, project administration, writing—original draft, writing—review and editing and visualisation. Millie Gaydon: investigation, methodology, formal analysis, project administration and writing—original draft. Sara Savar: investigation, methodology, formal analysis, project administration and writing—original draft. Marc Massetti: conceptualisation, methodology and writing—review and editing. Andrew Lloyd: conceptualisation, methodology and writing—review and editing. Gin Nie Chua: conceptualisation, investigation, methodology, formal analysis, project administration, writing—original draft, writing—review and editing, visualisation and validation.
: This study was conducted in compliance with the Declaration of Helsinki. Study materials were reviewed and deemed exempt by an institutional review board (Western Institutional Review Board [WIRB], IRB no.: 20241559).
: Informed consent was obtained from all participants prior to their involvement in the study.
: Informed consent for publication was obtained from all participants prior to their involvement in the study.
: The data that support the findings of this study are not publicly available, as they are proprietary to the study sponsor.
: Not available.